Navigation Links
Three Surgeons in East Texas Are Successfully Integrating a Novel Stem Cell Procedure for Spine Surgeries
Date:6/5/2009

Stem Cell Technologies for Surgery

TEXARKANA, Texas, June 5 /PRNewswire/ -- A new breakthrough in adult stem cell technology has three Texarkana neurosurgeons leading their industry by utilizing concentrated stem cells for spine surgery. The innovative technique is improving the desired results of surgical interventions for back pain. Leading researchers in the orthopedic and spine industry are predicting the latest developments in this field of medicine will become mainstream practice and, potentially, a standard of care for surgical treatments of severe back pain.

Dr. Lee Buono, Dr. Freddie Contreras, and Dr. J. Brett Dietze of Texarkana Neurological Associates are utilizing the new procedure that harnesses the healing potential of adult stem cells from a patient's own body. During surgeries for the neck and back, bone marrow is extracted from the hip through a small incision. The marrow is processed by an FDA-approved device and the living cells are delivered back to the surgeon in a concentrated dose to be implanted back into a patient to promote healing.

"We pride ourselves on our ability to offer the latest medical technology, right here in Texarkana. Improving our patient's quality of life is our number-one focus. This procedure is on the cutting edge of regenerative spine surgeries; it is a resource that must be considered as a standard for healing," Dr. Buono said. Dr. Dietze adds, "Biological graft materials have become a standard accessory in neurosurgery - autologous iliac crest autograft being the gold standard. Autologous bone graft is likely traumatic and time-consuming. My personal commitment to my patients to offer the most current advancements and treatment options is also an expectation held unanimous by Texarkana Neurological Associates. This surgical approach is without arguments on the cutting edge; the potential outcomes utilizing this technology may create an option for even the most
'/>"/>

SOURCE Texarkana Neurological Associates
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
2. Three Independent Studies Include the ImmuKnow(R) Assay to Manage and Optimize Immunosuppression Therapy in Transplant Patients
3. RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days
4. Three Clinical Presentations on Tapentadol Extended Release Tablets for Chronic Pain Featured at 2009 American Pain Society Annual Meeting
5. Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients
6. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
7. Abbotts Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years
8. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
9. Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium
10. Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL
11. Study Showed Prevention of Heart Attacks Within Three Months After Hospitalization Significantly Averted Future Heart Attacks and Death

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...K,Md.,Nov.25/PRNewswire-USNewswire/--RemediumTechn...amthatstopsseverebleeding,wonfirstprizeand$10,000i...curityChallenge2009,companyofficialsannouncetoday....world,Remedium,steampitchedtheirinventionattheGSCS...ness. ,, Remedium( www.remediumtechnologies.com...
(Date:11/25/2009)...v.25/PRNewswire/--Reportlinker.comannouncesthatane..., MammographyEquipment-AGlobalMarketPerspectiv...mmography-Equipment---A-Global-Market-Perspective....ializedaswellasdevelopingnationsisaprincipalfactor...scalatingawarenessaboutbreastcancerhasallowedwomen...
(Date:11/25/2009)...,N.C.,Nov.25/PRNewswire/--CempraPharmaceuticalsInc...ndchiefexecutiveofficer,willpresentatthePiperJaffr...mber1,2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr...adingantibioticclinicalprogramsforthetreatmentofdr...mpraPharmaceuticals ,, Foundedin2006,CempraPha...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Lumenis Completes 2415 Million Equity Financing From New and Existing Investors 50469 1Lumenis Completes 2415 Million Equity Financing From New and Existing Investors 50469 2Lumenis Completes 2415 Million Equity Financing From New and Existing Investors 50469 3Psoriasis Cure Now Welcomes Institute of Medicine Report Urging Comparative Effectiveness Research on Psoriasis But Worries About Risk of Rationing 50467 1Psoriasis Cure Now Welcomes Institute of Medicine Report Urging Comparative Effectiveness Research on Psoriasis But Worries About Risk of Rationing 50467 2Barriers Hinder EMS Workers From Using Best Resuscitation Practices 50465 1Barriers Hinder EMS Workers From Using Best Resuscitation Practices 50465 2Barriers Hinder EMS Workers From Using Best Resuscitation Practices 50465 3Barriers Hinder EMS Workers From Using Best Resuscitation Practices 50465 4
... Australia , May 22 The widely-used Affymetrix Wh...ay platform, normally used to assay gene expressio...ic splicing. Research published today in the open ... how to monitor alternative splicing activity on a...microarray technologies. , , Alternative splicing...
...-class treatment for inhalation anthrax - , , ROC...Nasdaq: HGSI ) today announced that it has submi...U.S. Food and Drug Administration (FDA) for its hu...mab) for the treatment of inhalation anthrax. , ...0080416/HGSLOGO ) , , The BLA submission incl...
Other Medicine Technology:Getting More From Whole-Transcript Microarrays 2Getting More From Whole-Transcript Microarrays 3Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM) 2Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM) 3Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM) 4
(Date:11/26/2009)...Newswire/--ThediabetespopulationintheUnitedStatesw...pendingonthediseaseisprojectedtohit$336billion,upf...eDecemberissueof DiabetesCare .TheNational Changin...k,commissionedtheanalysisbyateamfromtheUniversityo...Americanslivingwithdiabeteswillrisefrom23.7million...
(Date:11/26/2009)...e letters from the North Pole, Textsanta.net lets ...m Santa , North Pole, AK ...ficiencies at the North Pole Santa Claus has added... the globe informed of his Christmas progress at t... department have identified a large and growing pe...
(Date:11/25/2009)...swire-USNewswire/--WhenmostpeopleheartheacronymTMJ...vepatientsthehelptheyneed.TMJstandsfortheTemporal-...cts/connectswithyourskull(temporalbone). ,, The...ainwithchewing,clickingorpoppingofthejaw.Butmanyot...headaches,fatigue,sleepdisturbances,irritability,a...
(Date:11/25/2009)...PRNewswire/--Thanksgivingmealswillbedeliveredtoapp...chareathankstoFaithInAction/VolunteerActionforAgin...ionofSCANHealthPlan.Formorethan17yearstheseorganiz...mThanksgivingmealstoseniorsinneedinLongBeach,Lakew...ingcities. ,, "Ourwarmholidaymealsaredeliveredt...
(Date:11/25/2009)...lar cancer who were treated with cisplatin-based c...g neurological side effects and Raynaud-like pheno...apy, according to a new study published online Nov...stitute . , Marianne Brydy, M.D., of the Departm... Bergen, Norway, and colleagues conducted a cross-...
Breaking Medicine News(10 mins):Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
...ormerly of Harvard University,s Office of General ... All Legal Aspects of the Company, WALTHAM, Mass....leading research and advisory firms for pharmaceut...ny. Ms.,Silver comes to Decision Resources with an...
...URLINGTON, Mass., July 24 Palomar Medical,Technol...of laser- and,light-based devices for hair removal...terly conference call of its 2008 second quarter f...Time on,that day. The telephone replay will be ava...
... Chicago, 24 July 2008 The editors of Neurothera...uly issue, devoted to "Novel Therapeutics for Alzh...neurotherapeutics.org/ ) is the journal of the Ame...nference on Alzheimer,s Disease (ICAD), being held...
...Mark,s Breathe Easy Tour, Inspires Those with Chro...Enjoy Life, SAN DIEGO, July 24 SeQual Technologi...rk,s Breathe Easy Tour," a,SeQual-sponsored initia...h as chronic obstructive pulmonary,disease (COPD)....
...ATESVILLE, Ind., July 24 Hill-Rom Holdings,Inc.,s...release will be,issued Wednesday, August 6, 2008. ...following morning on Thursday, August 7, 2008 at 8...eased to,the public after the NYSE close on Wednes...
...EXICO CITY, July 24 New research from the Journal...issue on HIV/AIDS will be,released to the media, c...Four of the world,s top HIV/AIDS researchers will ... is embargoed until,10 a.m. (CT) Sun., Aug. 3, 200...
Other Medicine News:Health News:Lori Silver Joins Decision Resources, Inc. as General Counsel 2Health News:Palomar Medical Technologies to Host Second Quarter 2008 Financial Results Conference Call and Webcast on July 31, 2008 2Health News:Neurotherapeutics presents special issue on new treatments for Alzheimer's disease 2Health News:SeQual Technologies, American Lung Association of California and Seton Medical Center Partner to Support Survivor & Cyclist in 500-Mile California Ride 2Health News:SeQual Technologies, American Lung Association of California and Seton Medical Center Partner to Support Survivor & Cyclist in 500-Mile California Ride 3Health News:SeQual Technologies, American Lung Association of California and Seton Medical Center Partner to Support Survivor & Cyclist in 500-Mile California Ride 4Health News:Hill-Rom Holdings, Inc. Invites You to Join its Fiscal 2008 Third Quarter Earnings Webcast 2
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
Medicine Products: